VF
GRI

Virtu Financial’s GRI Bio GRI Stock Holding History

Virtu Financial’s Portfolio GRI Stock Details GRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-64
Closed -$25K – 1619
2024
Q4 		$25K Buy
+64
New +$21.9K ﹤0.01% 1266
2023
Q1 		– Hold
0
– -$30K – 1730
2022
Q4 		– Hold
0
– – – 1182
2022
Q3 		– Hold
0
– – – 1263

Other funds holding GRI

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Virtu Financial's GRI Position: Q1 2025 in Review

Virtu Financial sold out of GRI Bio (GRI) in Q1 2025, closing a stake of 64 shares — an estimated $25K sold.

Virtu Financial first reported a position in GRI in Q4 2024 and held it in 1 quarter. The position peaked at $25K in Q4 2024. 4 funds tracked by Wall St. Rank hold GRI as of Q1 2025.

  • Virtu Financial reported no remaining GRI Bio position as of Q1 2025 after selling out during the quarter.
  • Virtu Financial sold 64 GRI Bio shares in Q1 2025, an estimated $25K.
  • Virtu Financial first reported a position in GRI Bio in Q4 2024 and held it in 1 quarter.
  • Virtu Financial's GRI Bio position peaked at $25K in Q4 2024.
  • 4 funds tracked by Wall St. Rank held GRI Bio as of Q1 2025.

Based on Virtu Financial's 13F filing for Q1 2025, filed 12 May 2025.